Patents by Inventor Deanna Grote

Deanna Grote has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7854928
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: December 21, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen J. Russell, Adele Kay Fielding, Kah-Whye Peng, Deanna Grote
  • Publication number: 20100119548
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Application
    Filed: January 15, 2010
    Publication date: May 13, 2010
    Inventors: Stephen James Russell, Adele Fielding, Kah-Whye Peng, Deanna Grote
  • Patent number: 7670598
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: March 2, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen J. Russell, Adele Kay Fielding, Kah-Whye Peng, Deanna Grote
  • Publication number: 20090004149
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Application
    Filed: June 9, 2008
    Publication date: January 1, 2009
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Stephen James Russell, Adele Fielding, Kah-Whye Peng, Deanna Grote
  • Patent number: 7393527
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: July 1, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Adele Fielding, Kah-Whye Peng, Deanna Grote
  • Publication number: 20070071771
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Application
    Filed: September 18, 2006
    Publication date: March 29, 2007
    Inventors: Stephen Russell, Adele Fielding, Kah-Whye Peng, Deanna Grote
  • Patent number: 7118740
    Abstract: A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 103 pfus to about 1012 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: October 10, 2006
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Adele Fielding, Kah-Whye Peng, Deanna Grote